Ownership history in VANGUARD GROUP INC · 8 quarters on record
This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in MOLECULIN BIOTECH INC (MBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 15,544 | -224,375 | -93.5% | 0.00% | $51K | $3.31 |
| 2025 Q3 | ADDED | 239,919 | +208,984 | +675.6% | 0.00% | $127K | $13.25 |
| 2025 Q2 | UNCHANGED | 30,935 | — | 0% | 0.00% | $9K | $7.55 |
| 2025 Q1 | UNCHANGED | 30,935 | — | 0% | 0.00% | $30K | $24.35 |
| 2024 Q4 | REDUCED | 30,935 | -40,468 | -56.7% | 0.00% | $53K | $42.50 |
| 2024 Q3 | REDUCED | 71,403 | -13,015 | -15.4% | 0.00% | $203K | $71.00 |
| 2024 Q2 | ADDED | 84,418 | +9,118 | +12.1% | 0.00% | $297K | $88.00 |
| 2024 Q1 | INITIATED | 75,300 | — | — | 0.00% | $445K | — |
As of 2025 Q4 — sorted by position size